GleamWall
中文EN

ASTH Astrana Health, Inc.

Services-Management Consulting Services · Nasdaq · SEC CIK 1083446 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY35.1%
TTM net income YoY457.1%
TTM EPS YoY468.4%
Revenue 3-yr CAGR43.4%
Net income 3-yr CAGR6.0%

Margins

Gross margin11.0%
Operating margin3.1%
Net margin1.4%
FCF margin2.5%
EBITDA margin4.7%

Returns

ROE6.5%
ROA2.3%
ROIC (approx.)5.9%
Asset turnover1.71x

Leverage & solvency

Liabilities / assets73.1%
Debt / equity1.08x
Current ratio1.25x
Interest coverage1.87x

Cash quality & payout

Operating cash flow / net income2.15x
Accruals ratio-2.7%
Payout ratio5.1%
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$3.18B$2.03B
Cost of revenue$2.84B$1.76B
Gross profit$341.53M$271.39M
SG&A expense$217.26M$154.11M
Operating income$78.53M$89.35M
Interest expense$49.93M$33.10M
Pretax income$39.61M$80.82M
Income tax$15.53M$30.89M
Net income$22.49M$43.15M
EBITDA$124.27M$117.28M
EPS (basic)0.460.91
EPS (diluted)0.460.90
Weighted avg. shares (diluted)49.37M47.97M
Balance sheet
Cash & equivalents$429.47M$289.10M
Short-term investments—$2.38M
Receivables$374.46M$275.99M
Current assets$863.31M$638.50M
PP&E, net$57.33M$14.27M
Goodwill$865.30M$419.25M
Intangibles$270.97M$118.18M
Total assets$2.22B$1.35B
Current liabilities$615.27M$365.61M
Short-term debt$47.87M$9.38M
Long-term debt$990.90M$425.30M
Total debt$1.04B$434.67M
Total liabilities$1.66B$840.73M
Shareholders' equity$779.29M$712.72M
Net debt$609.29M$145.57M
Shares outstanding48.89M47.93M
Cash flow statement
Operating cash flow$114.60M$52.20M
Capital expenditure$10.11M$8.03M
Free cash flow$104.49M$44.17M
Investing cash flow-$539.00M-$192.40M
Financing cash flow$569.35M$135.15M
Depreciation & amortization$45.75M$27.93M
Stock-based compensation$38.60M$34.54M
Dividends paid$7.88M$4.04M
Share buybacks$25.60M$900,000

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.